The real-world observational study was designed to explore lymph metastases and prognoses of the Chinese patients with thoracic T1-T3 esophageal cancer
This trial is a real-world non-interventional observational study. The Chinese patients with thoracic T1-T3 esophageal cancer enrolled from Jan.1999 to Jun.2017 were included and the study data on pathologically diagnosed patient demographic/tumor biological characteristics were collected to evaluate the relevance of lymph metastases and prognoses of the subjects.
Study Type
OBSERVATIONAL
Enrollment
3,673
Radical resection of esophageal cancer
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China
RECRUITINGChina PLA General Hospital
Beijing, Beijing Municipality, China
RECRUITINGNumbers of lymph nodes and percentages of patients with surgeries
Numbers of lymph nodes and percentages of patients with surgeries in the patients with thoracic T1-T3 esophageal cancer
Time frame: 1999 - 2017
Impact factors of lymph metastases
Impact factors of lymph metastases
Time frame: 1999 - 2017
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Henan cancer hospital
Zhengzhou, Henan, China
RECRUITINGTongji Hospital Affiliated to Huazhong Technology Hospital
Wuhan, Hubei, China
RECRUITINGJiangsu cancer hospital
Nanjing, Jiangsu, China
RECRUITINGXi'an Tangdu Hospital
Xi'an, Shaanxi, China
RECRUITINGShanghai Chest Hospital
Shanghai, Shanghai Municipality, China
RECRUITINGHuaxi Hospital Affiliated to Sichuan University
Chengdu, Sichuan, China
RECRUITINGTianjin Chest Hospital
Tianjin, Tianjin Municipality, China
RECRUITINGFirst Hospital Affiliated to Zhejiang University
Hangzhou, Zhejiang, China
RECRUITING